Babak Tofighi, MD

  • Specialty: Internal Medicine
  • Language: English
  • Phone: 646-501-7743
View Locations

About Me

Conditions and Treatments



  • Assistant Professor, Department of Population Health
  • Assistant Professor, Department of Medicine
Board Certifications
  • American Board of Internal Medicine - Internal Medicine, 2012
Education and Training
  • MD from Saint George's University, 2012

Is this your profile?

Edit profile

Is this your profile?

Edit profile

Locations and Appointments

227 E. 30th St., TRB 6th Fl., Suite 631L
New York, NY 10016

Research My Research

Research Summary

Babak Tofighi is an Instructor in the Department of Population Health at the New York University School of Medicine and assistant director of the Addiction Medicine fellowship program at NYU and Bellevue Hospital Center.  Previously he completed a 1-year clinical fellowship in the newly initiated American Board of Addiction Medicine designated Addiction Medicine program at NYU and a 2-year NRSA-funded T32 primary care research fellowship (T32HP22238-01-00). He was during this same period a Research in Addiction Medicine Scholar (R25DA03211), and received additional training in health services research.  At Bellevue Hospital, he has been involved in expanding opioid and alcohol pharmacotherapies in primary care, and served as study physician for CTN-0051 (extended-release naltrexone versus buprenorphine opioid treatment, U10 DA013035) and as co-investigator for an NIH funded trial, extended-release naltrexone versus oral naltrexone for the treatment of alcohol use disorders in primary care (R01AA020836-01). He has also continued to study strategies for integrating mHealth-based interventions in Bellevue’s OBOT program.

Academic Contact

Academic office

227 East 30th Street

Seventh Floor

New York, NY 10016



Research Interests Timeline

These focus areas and their associated publications are derived from PubMed and the MeSH term library.
represents one publication


  • Tofighi, Babak; Abrantes, Ana; Stein, Michael D

    Medical clinics of North America. 2018 Jul; 102(4):715-731

  • Buprenorphine added on brief cognitive behavioral therapy for treatment of methamphetamine use disorder

    Shariatirad, S; Mahjoub, A; Haqiqi, A; Hemami, M R; Tofighi, B; Ekhtiari, H; Effatpanah, M

    Iranian journal of psychiatry & behavioral sciences. 2018 Jun 01; 12(2):

  • Extended-release vs. oral naltrexone for alcohol dependence treatment in primary care [Meeting Abstract]

    Malone, M; Vittitow, A; McDonald, R D; Tofighi, B; Garment, A; Schatz, D; Laska, E; Goldfeld, K; Rotrosen, J; Lee, J D

    Alcoholism: clinical & experimental research. 2018 June; (41st):64A

Read All Publications (33)